Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 1
1997 1
1999 1
2000 1
2001 3
2003 3
2004 1
2005 3
2006 1
2008 1
2009 1
2010 5
2011 10
2012 9
2013 11
2014 5
2015 11
2016 9
2017 7
2018 14
2019 17
2020 6
2021 5
2022 5
2023 7
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Results by year

Filters applied: . Clear all
Page 1
Huntington disease: natural history, biomarkers and prospects for therapeutics.
Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, Scahill RI, Leavitt BR, Stout JC, Paulsen JS, Reilmann R, Unschuld PG, Wexler A, Margolis RL, Tabrizi SJ. Ross CA, et al. Among authors: reilmann r. Nat Rev Neurol. 2014 Apr;10(4):204-16. doi: 10.1038/nrneurol.2014.24. Epub 2014 Mar 11. Nat Rev Neurol. 2014. PMID: 24614516 Free article. Review.
Parkinsonism in Huntington's disease.
Reilmann R. Reilmann R. Int Rev Neurobiol. 2019;149:299-306. doi: 10.1016/bs.irn.2019.10.006. Epub 2019 Nov 21. Int Rev Neurobiol. 2019. PMID: 31779817 Review.
Clinical Review of Juvenile Huntington's Disease.
Oosterloo M, Touze A, Byrne LM, Achenbach J, Aksoy H, Coleman A, Lammert D, Nance M, Nopoulos P, Reilmann R, Saft C, Santini H, Squitieri F, Tabrizi S, Burgunder JM, Quarrell O; Pediatric Huntington Disease Working Group of the European Huntington Disease Network. Oosterloo M, et al. Among authors: reilmann r. J Huntingtons Dis. 2024;13(2):149-161. doi: 10.3233/JHD-231523. J Huntingtons Dis. 2024. PMID: 38669553 Free PMC article. Review.
The pridopidine paradox in Huntington's disease.
Reilmann R. Reilmann R. Mov Disord. 2013 Sep;28(10):1321-4. doi: 10.1002/mds.25559. Epub 2013 Jul 11. Mov Disord. 2013. PMID: 23847099 No abstract available.
Technology in Parkinson's disease: Challenges and opportunities.
Espay AJ, Bonato P, Nahab FB, Maetzler W, Dean JM, Klucken J, Eskofier BM, Merola A, Horak F, Lang AE, Reilmann R, Giuffrida J, Nieuwboer A, Horne M, Little MA, Litvan I, Simuni T, Dorsey ER, Burack MA, Kubota K, Kamondi A, Godinho C, Daneault JF, Mitsi G, Krinke L, Hausdorff JM, Bloem BR, Papapetropoulos S; Movement Disorders Society Task Force on Technology. Espay AJ, et al. Among authors: reilmann r. Mov Disord. 2016 Sep;31(9):1272-82. doi: 10.1002/mds.26642. Epub 2016 Apr 29. Mov Disord. 2016. PMID: 27125836 Free PMC article. Review.
Fatigue-Related Changes of Daily Function: Most Promising Measures for the Digital Age.
Maetzler W, Correia Guedes L, Emmert KN, Kudelka J, Hildesheim HL, Paulides E, Connolly H, Davies K, Dilda V, Ahmaniemi T, Avedano L, Bouça-Machado R, Chambers M, Chatterjee M, Gallagher P, Graeber J, Maetzler C, Kaduszkiewicz H, Kennedy N, Macrae V, Carrasco Marin L, Moses A, Padovani A, Pilotto A, Ratcliffe N, Reilmann R, Rosario M, Schreiber S, De Sousa D, Van Gassen G, Warring LA, Seppi K, van der Woude CJ, Ferreira JJ, Ng WF; IDEA-FAST project consortium. Maetzler W, et al. Among authors: reilmann r. Digit Biomark. 2024 Mar 20;8(1):30-39. doi: 10.1159/000536568. eCollection 2024 Jan-Dec. Digit Biomark. 2024. PMID: 38510264 Free PMC article. Review.
131 results